Nuclera, a biotech company revolutionizing protein expression screening, has appointed Joseph Bertelsen as Chief Commercial Officer. With 20+ years in life science tools and drug development, Bertelsen brings valuable sales experience to drive adoption of Nuclera’s eProtein Discovery platform. Previously at the Institute for Protein Innovation, Diagenode, and Abcam, Bertelsen has a MSc in Pharmaceutical Medicine and a BSc in Chemical Engineering. Nuclera’s CEO, Dr. Michael Chen, is excited to work with Bertelsen to expand the platform’s reach and impact on the protein market. Bertelsen is enthusiastic about joining Nuclera at this pivotal moment in their journey to disrupt protein research.
Source link
Nuclera appoints Joseph Bertelsen as Chief Commercial Officer
